Karyopharm Therapeutics Inc. (KPTI) vs 4D pharma PLC Sponsored ADR (LBPS)

Karyopharm Therapeutics Inc. and 4D pharma PLC Sponsored ADR are both Biotechnology companies. Karyopharm Therapeutics Inc. and 4D pharma PLC Sponsored ADR are of similar size ($39.2M and $37.2M). Karyopharm Therapeutics Inc. has the higher net margin (−153.3% vs −9,577.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Karyopharm Therapeutics Inc. leads on 9 and 4D pharma PLC Sponsored ADR on 6.

Valuation

Metric KPTI LBPS Biotechnology median
P/E n/m n/m 7.88
P/S 0.32 211.23 11.47
P/B n/m 9.49 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.58 205.89 10.73
Earnings yield (874.99%) (40.76%) (28.84%)
Free cash flow yield (139.70%) (30.32%) (23.03%)

Profitability

Metric KPTI LBPS Biotechnology median
Gross margin 95.89% 0.00% 65.16%
Operating margin (56.17%) 0.00% 0.00%
Net margin (153.28%) (9,577.06%) 0.00%
Free cash flow margin (44.57%) (6,318.73%) 0.00%
Return on equity 78.98% (742.15%) (57.72%)
Return on assets (207.90%) (371.23%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KPTI LBPS Biotechnology median
Revenue growth (TTM) 6.81% — 5.64%
EPS growth (last fiscal year) (98.37%) 35.04% —
Revenue growth, 5-year CAGR 6.21% 21.70% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KPTI LBPS Biotechnology median
Debt to equity (0.76) 0.43 0.00
Current ratio 0.79 5.21 4.73
Net debt to EBITDA (2.03) 0.23 0.96

Dividend

Metric KPTI LBPS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric KPTI LBPS Biotechnology median
Market cap 39.24m 37.19m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack